Mr Carl Gibson, chief executive officer of Complementary Medicines Australia (CMA) has congratulated Catalent Australia Pty Ltd for its success as a grant recipient under the Next Generation Manufacturing Investment Programme for expansion of its high value manufacturing operations, as announced recently by Minister for Industry, Innovation and Science, the Hon Christopher Pyne MP.


Read the media release here